J. Goldman & CO LP Sc Pharmaceuticals Inc. Transaction History

J. Goldman & CO LP

$3.75 Billion
Q2 2025

A detailed history of J. Goldman & CO LP transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 121,500 shares of SCPH stock, worth $583,200. This represents 0.01% of its overall portfolio holdings.

Number of Shares

121,500

Previous 586,235 79.27%

Holding current value

$583,200

Previous $1.54 Million 70.02%

% of portfolio

0.01%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$2.02 - $4.27 $938,764 - $1.98 Million	-464,735 Reduced 79.27%	121,500 $462,000
Q1 2025 May 15, 2025	SELL	$2.63 - $3.68 $1.66 Million - $2.33 Million	-632,892 Reduced 51.91%	586,235 $1.54 Million
Q4 2024 Feb 14, 2025	SELL	$3.14 - $4.53 $505,119 - $728,722	-160,866 Reduced 11.66%	1,219,127 $4.32 Million
Q3 2024 Nov 14, 2024	BUY	$4.12 - $5.51 $2.1 Million - $2.81 Million	509,656 Added 58.56%	1,379,993 $6.29 Million
Q2 2024 Aug 14, 2024	SELL	$3.51 - $5.21 $871,561 - $1.29 Million	-248,308 Reduced 22.2%	870,337 $3.79 Million
Q1 2024 May 15, 2024	SELL	$4.86 - $6.39 $1.39 Million - $1.83 Million	-285,962 Reduced 20.36%	1,118,645 $5.62 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $6.63 $6.19 Million - $8.73 Million	1,316,700 Added 1497.83%	1,404,607 $8.81 Million
Q3 2023 Nov 14, 2023	BUY	$7.0 - $9.82 $221,585 - $310,852	31,655 Added 56.27%	87,907 $625,000
Q2 2023 Aug 14, 2023	SELL	$8.94 - $11.74 $100,575 - $132,075	-11,250 Reduced 16.67%	56,252 $573,000
Q1 2023 May 15, 2023	SELL	$5.59 - $9.47 $612,591 - $1.04 Million	-109,587 Reduced 61.88%	67,502 $612,000
Q4 2022 Feb 14, 2023	BUY	$4.02 - $7.53 $508,385 - $952,273	126,464 Added 249.81%	177,089 $1.27 Million
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.52 $226,800 - $330,075	50,625 New	50,625 $330,000
Q2 2022 Aug 15, 2022	SELL	$4.3 - $6.48 $290,250 - $437,400	-67,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.9 - $6.11 $1.18 Million - $1.85 Million	-302,591 Reduced 81.76%	67,500 $383,000
Q4 2021 Feb 14, 2022	SELL	$3.88 - $6.9 $1.64 Million - $2.91 Million	-422,330 Reduced 53.3%	370,091 $1.86 Million
Q3 2021 Nov 15, 2021	BUY	$4.93 - $7.15 $352,711 - $511,539	71,544 Added 9.92%	792,421 $5.27 Million
Q2 2021 Aug 16, 2021	BUY	$5.19 - $7.38 $2.71 Million - $3.86 Million	522,451 Added 263.3%	720,877 $4.41 Million
Q1 2021 May 17, 2021	BUY	$5.65 - $7.66 $1.12 Million - $1.52 Million	198,426 New	198,426 $1.32 Million

Others Institutions Holding SCPH

# of Institutions

101

Shares Held

37M

Call Options Held

757K

Put Options Held

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $132M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Account